MedPath

University of California, Los Angeles

University of California, Los Angeles logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private, Subsidiary
Established
1919-05-23
Employees
10K
Market Cap
-
Website
http://www.ucla.edu

Attention Training for Underserved Youth With Anxiety

Not Applicable
Completed
Conditions
Anxiety
Interventions
Behavioral: Attention Modification Program
Behavioral: Attention Control Condition
First Posted Date
2017-01-23
Last Posted Date
2022-07-26
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
69
Registration Number
NCT03028792
Locations
πŸ‡ΊπŸ‡Έ

Clinicas de Salud del Pueblo healthcare system, El Centro, California, United States

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Phase 4
Completed
Conditions
Wet Macular Degeneration
Interventions
Device: optovue angiovue
First Posted Date
2017-01-16
Last Posted Date
2022-01-06
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
26
Registration Number
NCT03022292
Locations
πŸ‡ΊπŸ‡Έ

Stein Eye Institute of UCLA, Los Angeles, California, United States

STI Screening as a Combined HIV Prevention Platform for MSM in Peru

Not Applicable
Completed
Conditions
Chlamydia of Rectum
HIV Infections
Gonorrhoea of Rectum
Interventions
Behavioral: Traditional Counseling
Behavioral: PCC
First Posted Date
2017-01-04
Last Posted Date
2018-08-07
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
150
Registration Number
NCT03010020
Locations
πŸ‡΅πŸ‡ͺ

Asociacion Civil Via Libre, Lima, Peru

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

Phase 1
Completed
Conditions
Severe Combined Immunodeficiency Due to ADA Deficiency
Interventions
Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)
Drug: PEG-ADA ERT
First Posted Date
2016-12-21
Last Posted Date
2022-08-03
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
10
Registration Number
NCT02999984
Locations
πŸ‡ΊπŸ‡Έ

University of California, Los Angeles, Los Angeles, California, United States

Testosterone for Fatigue in Men With MS

Phase 2
Withdrawn
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2016-12-21
Last Posted Date
2019-11-06
Lead Sponsor
University of California, Los Angeles
Registration Number
NCT03000127
Locations
πŸ‡ΊπŸ‡Έ

University of California, Los Angeles, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Washington University, Saint Louis, Missouri, United States

Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants

Not Applicable
Terminated
Conditions
Very Low Birth Weight Infant
Interventions
Other: cord milking
First Posted Date
2016-12-09
Last Posted Date
2018-10-15
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
5
Registration Number
NCT02987764
Locations
πŸ‡ΊπŸ‡Έ

Mattel Children's Hospital UCLA, Los Angeles, California, United States

Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease

Not Applicable
Completed
Conditions
Sickle Cell Disease
Interventions
Behavioral: Attention Control
Behavioral: Hypnosis
First Posted Date
2016-12-09
Last Posted Date
2020-11-04
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
25
Registration Number
NCT02987725
Locations
πŸ‡ΊπŸ‡Έ

University of California, Los Angeles, Los Angeles, California, United States

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

Not Applicable
Completed
Conditions
Women With an ENG Contraceptive Implant
Interventions
Procedure: continuation of ING implant
Procedure: removal of ENG implant
First Posted Date
2016-12-08
Last Posted Date
2021-04-30
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
40
Registration Number
NCT02986204
Locations
πŸ‡ΊπŸ‡Έ

UCLA Dept. OB/GYN, Women's Health CRU, 10833 Le Conte Ave, CHS 22-265, Los Angeles, California, United States

Improvement of Outcomes in Draf III/Endoscopic Modified Lothrop Procedure

Not Applicable
Withdrawn
Conditions
Frontal Sinusitis
Chronic Sinusitis
Interventions
Device: Porcine Intestinal submucosal xenograft
First Posted Date
2016-12-02
Last Posted Date
2020-10-30
Lead Sponsor
University of California, Los Angeles
Registration Number
NCT02981017
Locations
πŸ‡ΊπŸ‡Έ

University of California Los Angeles, Los Angeles, California, United States

MRA With Feraheme in HHT

Phase 1
Completed
Conditions
Hereditary Hemorrhagic Telangiectasia
Interventions
Procedure: Feraheme MRI/MRA
First Posted Date
2016-11-30
Last Posted Date
2019-01-25
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
10
Registration Number
NCT02977637
Locations
πŸ‡ΊπŸ‡Έ

UCLA, Los Angeles, California, United States

Β© Copyright 2025. All Rights Reserved by MedPath